Pharmaust Ltd
ASX:PAA

Watchlist Manager
Pharmaust Ltd Logo
Pharmaust Ltd
ASX:PAA
Watchlist
Price: 0.165 AUD -8.33% Market Closed
Market Cap: 81.2m AUD

Operating Margin

-668.7%
Current
Declining
by 413%
vs 3-y average of -255.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-668.7%
=
Operating Income
AU$-5.8m
/
Revenue
AU$866.2k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-668.7%
=
Operating Income
AU$-5.8m
/
Revenue
AU$866.2k

Peer Comparison

Country Company Market Cap Operating
Margin
AU
Pharmaust Ltd
ASX:PAA
81.2m AUD
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.8B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
217.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
221.8B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
213.9B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
No Stocks Found

Market Distribution

Lower than 79% of companies in Australia
Percentile
21th
Based on 2 656 companies
21th percentile
-668.7%
Low
-1 894 850% — -130.1%
Typical Range
-130.1% — 10.8%
High
10.8% — 145 596.9%
Distribution Statistics
Australia
Min -1 894 850%
30th Percentile -130.1%
Median 1.6%
70th Percentile 10.8%
Max 145 596.9%

Pharmaust Ltd
Glance View

Market Cap
81.2m AUD
Industry
Pharmaceuticals

PharmAust Ltd. is a pharmaceutical company, which provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2001-10-05. The firm is focused on developing therapeutics for cancer, neurodegenerative diseases and viral infections in humans and cancer for pet dogs. The firm's lead candidate, monepantel (MPL), is a small molecule drug primarily being developed as a safe and potent treatment for cancer. The MPL can also be used for neurodegenerative diseases such as Motor Neuron Disease, Parkinson's Disease, and Alzheimer's Disease. The company has completed Phase I clinical trials with MPL in humans and dogs diagnosed with solid tumors. The firm has also initiated a preclinical program to screen its portfolio of aminoacetonitrile (AAD) compounds for anticancer activity.

PAA Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-668.7%
=
Operating Income
AU$-5.8m
/
Revenue
AU$866.2k
What is Pharmaust Ltd's current Operating Margin?

The current Operating Margin for Pharmaust Ltd is -668.7%, which is below its 3-year median of -255.8%.

How has Operating Margin changed over time?

Over the last 3 years, Pharmaust Ltd’s Operating Margin has decreased from -34.3% to -668.7%. During this period, it reached a low of -668.7% on Jul 30, 2024 and a high of -13.5% on Dec 31, 2022.

Back to Top